211 related articles for article (PubMed ID: 10627219)
1. Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist.
Tsou K; Lowitz KA; Hohmann AG; Martin WJ; Hathaway CB; Bereiter DA; Walker JM
Neuroscience; 1996 Feb; 70(3):791-8. PubMed ID: 10627219
[TBL] [Abstract][Full Text] [Related]
2. A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
Nackley AG; Suplita RL; Hohmann AG
Neuroscience; 2003; 117(3):659-70. PubMed ID: 12617970
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat.
Hohmann AG; Tsou K; Walker JM
J Neurophysiol; 1999 Feb; 81(2):575-83. PubMed ID: 10036261
[TBL] [Abstract][Full Text] [Related]
4. Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord.
Presley RW; Menétrey D; Levine JD; Basbaum AI
J Neurosci; 1990 Jan; 10(1):323-35. PubMed ID: 1688935
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal cannabinoid administration suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in rat spinal cord: comparison with morphine.
Hohmann AG; Tsou K; Walker JM
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1132-6. PubMed ID: 11216448
[TBL] [Abstract][Full Text] [Related]
6. Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects.
Martin WJ; Hohmann AG; Walker JM
J Neurosci; 1996 Oct; 16(20):6601-11. PubMed ID: 8815936
[TBL] [Abstract][Full Text] [Related]
7. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
Nackley AG; Makriyannis A; Hohmann AG
Neuroscience; 2003; 119(3):747-57. PubMed ID: 12809695
[TBL] [Abstract][Full Text] [Related]
8. The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats.
Li J; Daughters RS; Bullis C; Bengiamin R; Stucky MW; Brennan J; Simone DA
Pain; 1999 May; 81(1-2):25-33. PubMed ID: 10353490
[TBL] [Abstract][Full Text] [Related]
9. Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain.
Liu C; Walker JM
J Neurophysiol; 2006 Dec; 96(6):2984-94. PubMed ID: 16943316
[TBL] [Abstract][Full Text] [Related]
10. Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociception.
Gutierrez T; Nackley AG; Neely MH; Freeman KG; Edwards GL; Hohmann AG
Brain Res; 2003 Oct; 987(2):176-85. PubMed ID: 14499961
[TBL] [Abstract][Full Text] [Related]
11. Pronociceptive effects of spinal dynorphin promote cannabinoid-induced pain and antinociceptive tolerance.
Gardell LR; Burgess SE; Dogrul A; Ossipov MH; Malan TP; Lai J; Porreca F
Pain; 2002 Jul; 98(1-2):79-88. PubMed ID: 12098619
[TBL] [Abstract][Full Text] [Related]
12. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-fos expression.
Gogas KR; Presley RW; Levine JD; Basbaum AI
Neuroscience; 1991; 42(3):617-28. PubMed ID: 1659673
[TBL] [Abstract][Full Text] [Related]
13. Nitrous oxide suppresses tonic and phasic nociceptive behaviors but not formalin-induced c-Fos expression in the rat spinal cord dorsal horn.
Lin FS; Shyu BC; Shieh JY; Sun WZ
Acta Anaesthesiol Sin; 2003 Sep; 41(3):115-23. PubMed ID: 14601197
[TBL] [Abstract][Full Text] [Related]
14. Induction and suppression of immediate-early genes in the rat brain by a selective alpha-2-adrenoceptor agonist and antagonist following noxious peripheral stimulation.
Pertovaara A; Bravo R; Herdegen T
Neuroscience; 1993 May; 54(1):117-26. PubMed ID: 8100045
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2.
Hohmann AG; Martin WJ; Tsou K; Walker JM
Life Sci; 1995; 56(23-24):2111-8. PubMed ID: 7776839
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid WIN 55,212-2 inhibits the activity-dependent facilitation of spinal nociceptive responses.
Strangman NM; Walker JM
J Neurophysiol; 1999 Jul; 82(1):472-7. PubMed ID: 10400973
[TBL] [Abstract][Full Text] [Related]
17. The rodent amygdala contributes to the production of cannabinoid-induced antinociception.
Manning BH; Martin WJ; Meng ID
Neuroscience; 2003; 120(4):1157-70. PubMed ID: 12927220
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms.
Johanek LM; Heitmiller DR; Turner M; Nader N; Hodges J; Simone DA
Pain; 2001 Sep; 93(3):303-315. PubMed ID: 11514089
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of NMDA and AMPA/KA receptor antagonists on c-Fos or Zif/268 expression in the rat spinal dorsal horn induced by noxious thermal or mechanical stimulation, or formalin injection.
Rahman OI; Terayama R; Ikeda T; Koganemaru M; Nakamura T; Shiba R; Nishimori T
Neurosci Res; 2002 Aug; 43(4):389-99. PubMed ID: 12135782
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats.
Lim G; Sung B; Ji RR; Mao J
Pain; 2003 Sep; 105(1-2):275-83. PubMed ID: 14499445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
